ForSight spinoff acquired by QLT Inc.

Forsight Newco II Inc., a privately-held spinoff of ForSight Labs LLC, has agreed to be acquired by QLT Inc. (QLTI) for $42 million as well as future milestone payments and royalties on net sales of products.

The acquisition includes rights to a proprietary ocular punctual plug drug delivery system, which may have potential as a treatment for glaucoma.

ForSight Labs LLC, an ophthalmic technology incubator backed by Menlo Park investment firm Morgenthaler Ventures, Split Rock Partners and Versant Ventures, spun off its first company, Transcend Medical Inc., in late 2006.

businessBusiness & Real Estate

If you find our journalism valuable and relevant, please consider joining our Examiner membership program.
Find out more at www.sfexaminer.com/join/

Just Posted

Struggling Chinatown restaurants get help moving business outdoors

A total of $25,000 will be distributed to assist with costs of Shared Spaces program

Nomination delays, vacancies impair SFMTA board’s ability to vote

Supervisors to consider mayor’s nominees on Aug. 10

District 7 race leads supervisor contests in campaign contributions

The race to replace outgoing Board of Supervisors President Norman Yee has… Continue reading

Jones Street getting more pedestrian space after months of community pressure

Pedestrians on Jones Street will have more room to walk as early… Continue reading

Pandemic exacerbates food insecurity for San Franciscans in need

Mayor Breed proposes $45.7 million for meal programs under two-year budget

Most Read